Clinical Trials · NCT01160315
Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure
- Phase
- Phase 2/Phase 3
- Recruitment status
- Completed
- Sponsor
- Erasme University Hospital
- Enrollment
- 118
- Start date
- Jul 2002
- Locations
- 15 sites, 3 countries
- Primary endpoint
- Premature ovarian failure rate